$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

IL-12 gene therapy of tumors 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-048/00
  • C12N-015/00
  • C12N-015/87
출원번호 US-0659206 (1996-06-05)
발명자 / 주소
  • Rakhmilevich Alexander L.
  • Yang Ning-Sun
출원인 / 주소
  • Powderject Vaccines, Inc.
대리인 / 주소
    Robins & AssociatesMcCracken
인용정보 피인용 횟수 : 47  인용 특허 : 3

초록

In an approach to genetic therapy for treating tumors, a genetic construction encoding the p35 and p40 subunits of the cytokine IL-12 is delivered into cells of individuals in need of therapy so as to express IL-12 in cells and to cause regression of established tumors.

대표청구항

[ We claim:] [1.] A method of treating tumors in a mammal, comprising:a) providing a vector comprising an expressible genetic construct, wherein said genetic construct comprises a first DNA sequence encoding a p35 subunit of IL-12 and a second DNA sequence encoding a p40 subunit of IL-12, wherein sa

이 특허에 인용된 특허 (3)

  1. McCabe Dennis E. (Middleton WI) Martinell Brian J. (Madison WI), Apparatus for genetic transformation.
  2. Sanford John C. (Geneva NY) Wolf Edward D. (Ithaca NY) Allen Nelson K. (Newfield NY), Method for transporting substances into living cells and tissues and apparatus therefor.
  3. Christou Paul (Madison WI) McCabe Dennis (Middleton WI) Swain William F. (Madison WI) Barton Kenneth A. (Middleton WI), Particle-mediated transformation of soybean plants and lines.

이 특허를 인용한 특허 (47)

  1. Walker, Patricia S., Botulinum toxin administration to treat various conditions.
  2. Walker, Patricia S., Botulinum toxin administration to treat various conditions.
  3. Walker,Patricia S., Botulinum toxin for treating postherpetic neuralgia.
  4. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, Cancer treatments including administering IL-2 fusion proteins with modulated selectivity.
  5. Leong,Steven R.; Punnonen,Juha, Cytokine polypeptides.
  6. Gillies, Stephen D.; Stein, Pascal Andre; Lo, Kin-Ming, DNA encoding IL-2 fusion proteins with modulated selectivity.
  7. Beech, Robert P.; Reed, Thomas D., Engineered cells expressing multiple immunomodulators and uses thereof.
  8. Beech, Robert P.; Reed, Thomas D., Engineered cells expressing multiple immunomodulators and uses thereof.
  9. Gillies, Stephen D.; Lan, Yan; Holden, Sylvia, Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents.
  10. Gillies, Stephen D.; Burger, Christa; Lo, Kin-Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  11. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  12. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  13. Way,Jeffrey, Erythropoietin forms with improved properties.
  14. Gillies,Stephen D.; Lo,Kin Ming, Expression technology for proteins containing a hybrid isotype antibody moiety.
  15. Gillies,Stephen D.; Lo,Kin Ming; Wesolowski, Jr.,John S., Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens.
  16. Gillies, Stephen D.; Lo, Kin Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  17. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  18. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  19. Gillies,Stephen D.; Lo,Kin Ming; Lan,Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  20. Felber, Barbara; Pavlakis, George N.; Rosati, Margherita, IL-12 for expression in mammalian cell.
  21. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, IL-2 fusion proteins with modulated selectivity.
  22. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Immunocytokine sequences and uses thereof.
  23. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Immunocytokine sequences and uses thereof.
  24. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan X., Immunocytokine sequences and uses thereof.
  25. Smolyarov, Boris V.; Rogatchev, Victor T., Injector assembly with driving means and locking means.
  26. Gillies, Stephen; Lo, Kin-Ming; Lan, Yan; Verma, Rakesh, Interleukin-12 targeted to oncofoetal fibronectin.
  27. Webster, Gordon D.; McKenzie, Suzanne P.; Lo, Kin-Ming; Stein, Pascal André , Interleukin-12p40 variants with improved stability.
  28. Smoliarov, Boris V.; Rogatchev, Victor T.; Katov, Victor N.; Felton, Alan; Leon, Nathaniel, Method and apparatus for removing cap from medical device.
  29. Li,Chuan Yuan; Huang,Qian; Dewhirst,Mark W., Method for selective expression of therapeutic genes by hyperthermia.
  30. Walker,Patricia S., Methods of administering botulinum toxin.
  31. Gillies, Stephen D.; Lo, Kin Ming, Methods of targeting multiple cytokines.
  32. Webster, Gordon D.; McKenzie, Suzanne P.; Lo, Kin-Ming; Stein, Pascal André, Methods of treating cancer using interleukin-12p40 variants having improved stability.
  33. Gillies, Stephen D.; Lo, Kin-Ming; Wesolowski, Jr., John S., Methods of using Fc-cytokine fusion proteins.
  34. Gillies, Stephen D.; Lo, Kin-Ming, Multiple cytokine protein complexes.
  35. Gillies,Stephen D.; Lo,Kin Ming, Multiple cytokine protein complexes.
  36. Webster, Gordon D.; McKenzie, Suzanne P.; Lo, Kin-Ming; Stein, Pascal A., Nucleic acids encoding interleukin-12P40 variants with improved stability.
  37. Gillies, Stephen D.; Way, Jeffrey; Lo, Kin-Ming, Proteins comprising an IgG2 domain.
  38. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Recombinant tumor specific antibody and use thereof.
  39. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  40. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  41. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  42. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  43. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  44. Gillies,Stephen D.; Hamilton,Anita A., Reducing the immunogenicity of fusion proteins.
  45. Smolyarov, Boris V.; Rogatchev, Victor T.; Katov, Victor N.; Leon, Nathaniel, Safety mechanism to prevent accidental patient injection and methods of same.
  46. Yarchoan, Robert; Pluda, James M.; Wyvill, Kathleen; Lietzau, Jill; Shearer, Gene M.; Feigal, Ellen; Tosato, Giovanna; Little, Richard; Sherman, Matthew L., Treatment of Kaposi's sarcoma with IL-12.
  47. Smoliarov, Boris V.; Rogatchev, Victor T.; Katov, Victor N.; Felton, Alan; Leon, Nathaniel, Universal anti-infectious protector for needleless injectors.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로